BioLineRx (BLRX) Says Genentech Commenced Phase 1b/2 Trial for BL-8040 in Gastric Cancer Under Immunotherapy Collaboration
Tweet Send to a Friend
BioLineRx Ltd. (NASDAQ: BLRX) announced today that Genentech, a member of the Roche Group, has commenced a Phase 1b/2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
